TWI670016B - Use of yeast extract - Google Patents
Use of yeast extract Download PDFInfo
- Publication number
- TWI670016B TWI670016B TW104109904A TW104109904A TWI670016B TW I670016 B TWI670016 B TW I670016B TW 104109904 A TW104109904 A TW 104109904A TW 104109904 A TW104109904 A TW 104109904A TW I670016 B TWI670016 B TW I670016B
- Authority
- TW
- Taiwan
- Prior art keywords
- glutathione
- yeast extract
- melanin production
- yeast
- effect
- Prior art date
Links
- 229940041514 candida albicans extract Drugs 0.000 title claims abstract description 42
- 239000012138 yeast extract Substances 0.000 title claims abstract description 42
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 claims abstract description 110
- 108010024636 Glutathione Proteins 0.000 claims abstract description 55
- 229960003180 glutathione Drugs 0.000 claims abstract description 51
- 230000008099 melanin synthesis Effects 0.000 claims abstract description 28
- 239000003112 inhibitor Substances 0.000 claims description 9
- 240000004808 Saccharomyces cerevisiae Species 0.000 abstract description 15
- 235000013305 food Nutrition 0.000 abstract description 13
- 230000002401 inhibitory effect Effects 0.000 abstract description 13
- 230000000694 effects Effects 0.000 abstract description 9
- 239000002537 cosmetic Substances 0.000 abstract description 5
- 230000003078 antioxidant effect Effects 0.000 abstract description 4
- 239000000126 substance Substances 0.000 abstract description 4
- 208000001382 Experimental Melanoma Diseases 0.000 abstract description 2
- 239000000825 pharmaceutical preparation Substances 0.000 abstract description 2
- 229940127557 pharmaceutical product Drugs 0.000 abstract description 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 238000000605 extraction Methods 0.000 description 21
- 210000004027 cell Anatomy 0.000 description 10
- 238000000034 method Methods 0.000 description 10
- 239000000203 mixture Substances 0.000 description 10
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 8
- 210000003491 skin Anatomy 0.000 description 8
- 208000012641 Pigmentation disease Diseases 0.000 description 7
- 230000019612 pigmentation Effects 0.000 description 7
- 238000003756 stirring Methods 0.000 description 7
- 102000004190 Enzymes Human genes 0.000 description 6
- 108090000790 Enzymes Proteins 0.000 description 6
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 4
- 238000005119 centrifugation Methods 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 239000008188 pellet Substances 0.000 description 4
- 239000002953 phosphate buffered saline Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 210000005253 yeast cell Anatomy 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 239000003513 alkali Substances 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 230000006866 deterioration Effects 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000235646 Cyberlindnera jadinii Species 0.000 description 2
- 108010053070 Glutathione Disulfide Proteins 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 239000004365 Protease Substances 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 2
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 2
- 235000011130 ammonium sulphate Nutrition 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 235000012631 food intake Nutrition 0.000 description 2
- YPZRWBKMTBYPTK-BJDJZHNGSA-N glutathione disulfide Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@H](C(=O)NCC(O)=O)CSSC[C@@H](C(=O)NCC(O)=O)NC(=O)CC[C@H](N)C(O)=O YPZRWBKMTBYPTK-BJDJZHNGSA-N 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 2
- 235000019341 magnesium sulphate Nutrition 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- YPZRWBKMTBYPTK-UHFFFAOYSA-N oxidized gamma-L-glutamyl-L-cysteinylglycine Natural products OC(=O)C(N)CCC(=O)NC(C(=O)NCC(O)=O)CSSCC(C(=O)NCC(O)=O)NC(=O)CCC(N)C(O)=O YPZRWBKMTBYPTK-UHFFFAOYSA-N 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001103 potassium chloride Substances 0.000 description 2
- 235000011164 potassium chloride Nutrition 0.000 description 2
- 239000001540 sodium lactate Substances 0.000 description 2
- 235000011088 sodium lactate Nutrition 0.000 description 2
- 229940005581 sodium lactate Drugs 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 1
- 239000004254 Ammonium phosphate Substances 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 244000018436 Coriandrum sativum Species 0.000 description 1
- 235000002787 Coriandrum sativum Nutrition 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- 241000006364 Torula Species 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- LFVGISIMTYGQHF-UHFFFAOYSA-N ammonium dihydrogen phosphate Chemical compound [NH4+].OP(O)([O-])=O LFVGISIMTYGQHF-UHFFFAOYSA-N 0.000 description 1
- 229910000387 ammonium dihydrogen phosphate Inorganic materials 0.000 description 1
- 229910000148 ammonium phosphate Inorganic materials 0.000 description 1
- 235000019289 ammonium phosphates Nutrition 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 235000015895 biscuits Nutrition 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 229910052793 cadmium Inorganic materials 0.000 description 1
- BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 description 1
- 235000012970 cakes Nutrition 0.000 description 1
- YYRMJZQKEFZXMX-UHFFFAOYSA-N calcium;phosphoric acid Chemical compound [Ca+2].OP(O)(O)=O.OP(O)(O)=O YYRMJZQKEFZXMX-UHFFFAOYSA-N 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 229910002091 carbon monoxide Inorganic materials 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 229910000365 copper sulfate Inorganic materials 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- MNNHAPBLZZVQHP-UHFFFAOYSA-N diammonium hydrogen phosphate Chemical compound [NH4+].[NH4+].OP([O-])([O-])=O MNNHAPBLZZVQHP-UHFFFAOYSA-N 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000019441 ethanol Nutrition 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000012091 fetal bovine serum Substances 0.000 description 1
- 239000012737 fresh medium Substances 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- -1 iron ions Chemical class 0.000 description 1
- 229910000358 iron sulfate Inorganic materials 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000003120 macrolide antibiotic agent Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 235000011147 magnesium chloride Nutrition 0.000 description 1
- 229940099596 manganese sulfate Drugs 0.000 description 1
- 239000011702 manganese sulphate Substances 0.000 description 1
- 235000007079 manganese sulphate Nutrition 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 229940126601 medicinal product Drugs 0.000 description 1
- 210000002752 melanocyte Anatomy 0.000 description 1
- 201000001441 melanoma Diseases 0.000 description 1
- 235000020124 milk-based beverage Nutrition 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- 235000019837 monoammonium phosphate Nutrition 0.000 description 1
- 239000006012 monoammonium phosphate Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 210000004694 pigment cell Anatomy 0.000 description 1
- 229920002098 polyfluorene Polymers 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 235000011118 potassium hydroxide Nutrition 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 235000011962 puddings Nutrition 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000007665 sagging Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 235000015170 shellfish Nutrition 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000009331 sowing Methods 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 230000036561 sun exposure Effects 0.000 description 1
- 239000002426 superphosphate Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
- 239000007222 ypd medium Substances 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
- 229960001763 zinc sulfate Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/14—Yeasts or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
- A61K38/063—Glutathione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9728—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Mycology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Birds (AREA)
- General Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nutrition Science (AREA)
- Toxicology (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Cosmetics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
麩胱甘肽雖已知有高度的黑色素產生抑制作用或抗氧化作用等各種的美容效果,但在日本國內仍是歸類為醫藥品而無法利用於作為食品。然而,尤以近年來食品要求此種機能。 Although glutathione is known to have various cosmetic effects such as a high melanin production inhibitory effect and antioxidant effect, it is still classified as a pharmaceutical product in Japan and cannot be used as a food. However, especially in recent years, such functions are required in foods.
針對萃取自有食用經驗且安全性被認可之酵母的含麩胱甘肽之酵母萃取物,利用小鼠B16黑色素瘤細胞來確認抑制黑色素產生的效果,結果確認了:與同濃度的麩胱甘肽單質相比可獲得2倍以上之優良的黑色素產生抑制效果。 A mouse B16 melanoma cell was used to confirm the effect of inhibiting melanin production on a glutathione-containing yeast extract extracted from a yeast that has been edible and recognized for its safety. The results confirmed that the same concentration of glutathione Compared with peptide simple substance, the melanin production inhibitory effect can be more than doubled.
Description
本發明提供利用有食用經驗且安全性被認可的酵母,於菌體培養後萃取出酵母萃取物,利用所得酵母萃取物及麩胱甘肽的黑色素產生抑制劑。 The invention provides the use of yeast with edible experience and recognized safety, extracting a yeast extract after bacterial cell culture, and using the obtained yeast extract and a melanin production inhibitor of glutathione.
抗衡因年齡增長、壓力、暴露於紫外線等原因所引起的色斑、皺紋、鬆弛等皮膚症狀的惡化而美麗地保持肌膚的美觀,對於女性而言為關切的要事。因此,吾人謀求用以預防或改善皮膚症狀的惡化之手段,迄此已完成各種研究。特別是,色斑、斑點、日曬後之色素沉澱等已知係因存在於皮膚之色素細胞(黑色素細胞)的活化使黑色素生成顯著亢進而引起。作為用以預防或改善此等色素沉澱所涉及之皮膚症狀的惡化的素材之一,已知有麩胱甘肽。 It is important for women to counteract the deterioration of skin symptoms such as pigmentation, wrinkles, and sagging caused by age, stress, and exposure to ultraviolet rays, and to maintain beautiful skin. Therefore, I have sought various means for preventing or improving the deterioration of skin symptoms, and various studies have been completed so far. In particular, it is known that pigmentation, spots, pigmentation after sun exposure, and the like are caused by the activation of pigment cells (melanocytes) existing in the skin, which significantly increases melanin production. As one of the materials for preventing or improving the deterioration of the skin symptoms involved in these pigmentation, glutathione is known.
麩胱甘肽係指麩胺酸、半胱胺酸、甘胺酸此三種胺基酸鍵結而成的三肽,具有作為在細胞內保護細胞免於活性氧或過氧化物質侵害之抗氧化物質的作用、或將異物排出至細胞外之解毒作用等生物體內重要的作用。在肌膚中,活 性氧亦屬黑色素色素的產生原因,據認為藉由麩胱甘肽的抗氧化作用可抑制色斑、色素沉澱。 Glutathione refers to a tripeptide that is a bond of three amino acids, glutamic acid, cysteine, and glycine. It has the antioxidant function of protecting cells from reactive oxygen or peroxidants in cells Important effects in living organisms, such as the action of substances, or the detoxification of foreign matter that is excreted out of cells. In the skin, live Sexual oxygen is also the cause of melanin pigmentation, and it is thought that pigmentation and pigmentation can be suppressed by the antioxidant effect of glutathione.
[先前技術文獻] [Prior technical literature]
[專利文獻] [Patent Literature]
[專利文獻1]日本特開2002-29920號公報 [Patent Document 1] Japanese Patent Laid-Open No. 2002-29920
麩胱甘肽雖已知有高度的黑色素產生抑制作用或抗氧化作用等各種的美容效果,但在日本仍是歸類為醫藥品而無法利用於作為食品。 Although glutathione is known to have various cosmetic effects such as a high melanin production inhibitory effect and antioxidant effect, it is still classified as a pharmaceutical in Japan and cannot be used as a food.
本發明之課題為提供作為食品、或醫藥品等之安全性高且美白效果優良的黑色素產生抑制劑。 An object of the present invention is to provide a melanin production inhibitor having high safety and excellent whitening effect as a food or a pharmaceutical.
吾人有鑒於此實情而致力重複研究,發現:利用有食用經驗且安全性受認可的圓酵母(Torula yeast),於菌體培養後萃取出酵母萃取物,所得富含麩胱甘肽之酵母萃取物具有較麩胱甘肽單獨時更高的黑色素產生抑制效果,而完成本發明。 In view of this fact, I have been working hard to repeat the research and found that: Torula yeast, which has experience in food consumption and is recognized as safe, extracts yeast extract after bacterial culture, and the resulting glutathione-rich yeast extract The compound has a higher melanin production inhibitory effect than that of glutathione alone, and completed the present invention.
亦即,本發明提供: (1)一種黑色素產生抑制劑,其含有酵母萃取物及麩胱甘肽;(2)一種飲食品,其含有如(1)之黑色素產生抑制劑;(3)一種化妝品,其含有如(1)之黑色素產生抑制劑;(4)一種醫藥品,其含有如(1)之黑色素產生抑制劑。 That is, the present invention provides: (1) a melanin production inhibitor containing yeast extract and glutathione; (2) a food and drink product containing a melanin production inhibitor such as (1); (3) a cosmetic product containing (1) ), A melanin production inhibitor; (4) A pharmaceutical product containing a melanin production inhibitor such as (1).
針對萃取自有食用經驗且安全性受認可之食用酵母的含麩胱甘肽之酵母萃取物,利用小鼠B16黑色素瘤細胞來確認黑色素產生抑制的效果,結果確認了:與同濃度的麩胱甘肽單獨時相比可獲得2倍以上之優良的黑色素產生抑制效果。 A mouse B16 melanoma cell was used to confirm the effect of suppressing melanin production on a glutathione-containing yeast extract extracted from a edible yeast that has experience in food consumption and is recognized for its safety. Compared to glycine alone, it has more than two times better melanin production inhibitory effect.
1‧‧‧對照組 1‧‧‧control group
2‧‧‧麩胱甘肽 2‧‧‧glutathione
3‧‧‧本案發明(含麩胱甘肽之酵母萃取物) 3‧‧‧ Invention of the case (yeast extract containing glutathione)
4‧‧‧正對照(乳酸鈉) 4‧‧‧ Positive control (sodium lactate)
圖1顯示黑色素產生抑制效果。 Figure 1 shows the melanin production inhibitory effect.
本發明所使用的酵母可無特別限制地使用。舉例來說,若萃取自含有麩胱甘肽的酵母時,由於可獲得含酵母萃取物與麩胱甘肽的含麩胱甘肽之酵母萃取物,因而較佳。特佳之酵母係一般名稱稱為「圓酵母」的高蛋白假絲酵母(Candida utilis)。酵母的培養形式不特別限制,一般係使用批次培養、或連續培養任一種。培養基亦可使用一般所使用者。舉例來說,作為碳源,可使用葡萄糖、乙酸、乙醇、甘油、糖蜜、亞硫酸紙漿廢液等。作為氮源,可使用尿素、氨、硫酸銨、 氯化銨、硝酸鹽等。就磷酸、鉀、鎂源而言,亦以過磷酸石灰、磷酸銨、氯化鉀、氫氧化鉀、硫酸鎂、氯化鎂等一般的工業用原料為佳。此外,一般係添加鋅、銅、錳、鐵離子等無機鹽。又,亦有添加維生素、胺基酸、核酸相關物質等者。尚可添加酪蛋白、酵母萃取物、肉萃取物、腖等的有機物。培養溫度為21~37℃,較佳為25~34℃;pH為3.0~8.0,尤以3.5~7.0為佳。由於胺基酸或核酸的生產性會隨培養條件而變動,因此因應目標之酵母萃取物的製品規格來進行條件設定。 The yeast used in the present invention can be used without particular limitation. For example, when extracted from a glutathione-containing yeast, it is preferable to obtain a glutathione-containing yeast extract containing a yeast extract and glutathione. A particularly good yeast line is Candida utilis, commonly known as "round yeast". The culture form of the yeast is not particularly limited, and generally, either batch culture or continuous culture is used. The medium can also be used by ordinary users. For example, as the carbon source, glucose, acetic acid, ethanol, glycerin, molasses, sulfurous acid pulp waste liquid, and the like can be used. As the nitrogen source, urea, ammonia, ammonium sulfate, Ammonium chloride, nitrate, etc. As for the sources of phosphoric acid, potassium, and magnesium, general industrial raw materials such as superphosphate lime, ammonium phosphate, potassium chloride, potassium hydroxide, magnesium sulfate, and magnesium chloride are also preferred. In addition, inorganic salts such as zinc, copper, manganese, and iron ions are generally added. In addition, vitamins, amino acids, and nucleic acid-related substances are also added. Organic substances such as casein, yeast extract, meat extract, coriander can still be added. The culture temperature is 21 to 37 ° C, preferably 25 to 34 ° C; the pH is 3.0 to 8.0, and preferably 3.5 to 7.0. Since the productivity of amino acids or nucleic acids varies depending on the culture conditions, the conditions are set in accordance with the product specifications of the target yeast extract.
於菌體培養後由酵母菌體進行萃取。萃取法無特別限制,一般而言,可藉由自消化法、熱水萃取法、酵素萃取法、酸或鹼萃取法、或此等之組合來進行。 After the bacterial cells are cultured, the yeast cells are extracted. The extraction method is not particularly limited, and generally, it can be performed by a self-digestion method, a hot water extraction method, an enzyme extraction method, an acid or alkali extraction method, or a combination thereof.
藉由自消化進行萃取時,例如,在55℃下攪拌4小時。如採酵素萃取法,係以細胞壁溶解酵素或蛋白酶等進行攪拌萃取。如採酸萃取法,係以硫酸等調整成酸性後進行萃取。如採鹼萃取法,則調整成鹼性後進行萃取。於自消化後(例如在55℃下攪拌4小時),亦可採進行酵素萃取等的組合。 When extraction is performed by autodigestion, for example, it is stirred at 55 ° C for 4 hours. For example, the enzyme extraction method uses cell wall to dissolve enzymes or proteases for stirring extraction. For example, the acid extraction method is performed after the acid is adjusted to be acidic with sulfuric acid or the like. In the case of alkali extraction, extraction is performed after adjustment to alkalinity. After self-digestion (for example, stirring at 55 ° C for 4 hours), a combination of enzyme extraction and the like may be used.
萃取後,以離心分離將酵母殘渣分離,於濃縮後進行冷凍乾燥或熱風乾燥,由此可得含麩胱甘肽之酵母萃取物。酵母萃取物中所含之麩胱甘肽可為還原型麩胱甘肽、氧化型麩胱甘肽、及此等之混合物的任一種。酵母萃取物中的麩胱甘肽含量,只要在酵母萃取物中含有麩胱甘肽即可。例如為含有3質量%以上,較佳為10質量%以上之麩胱甘肽的酵母萃取物。更佳為在乾燥酵母萃取物中含有15質量%以上之麩胱甘肽的酵母萃取物。為使酵母萃取物中的麩胱甘肽含量達 15%以上,培養酵母中的麩胱甘肽含量愈高愈佳,據此,依前述之萃取法萃取出酵母萃取物者的效率較好。作為提高酵母中的麩胱甘肽含量之方法,宜為周知之方法。例如有對培養基中添加鋅離子的方法(日本特開2000-279164號公報);以鎘耐性、巨環內酯系抗生物質耐性為指標的富含麩胱甘肽之酵母株的取得方法(日本特開2006-42637號公報、日本特開2006-42638號公報)。如日本特開2011-103789號公報所述,亦可藉由變異酵母菌體萃取獲得。又,亦可使用一般販售的酵母萃取物。例如有KOHJIN Life Sciences公司製「Hithionextract」YH-15、YH-D18等。 After extraction, the yeast residue is separated by centrifugation, and concentrated and then freeze-dried or hot air dried to obtain a yeast extract containing glutathione. The glutathione contained in the yeast extract may be any of reduced glutathione, oxidized glutathione, and mixtures thereof. The content of glutathione in the yeast extract may be any content as long as the glutathione is contained in the yeast extract. For example, it is a yeast extract containing glutathione of 3 mass% or more, Preferably it is 10 mass% or more. More preferably, it is a yeast extract which contains 15 mass% or more of glutathione in a dry yeast extract. In order to maximize the content of glutathione in yeast extract Above 15%, the higher the content of glutathione in the cultured yeast, the better. According to this, the efficiency of extracting the yeast extract according to the aforementioned extraction method is better. As a method for increasing the content of glutathione in yeast, a known method is preferred. For example, there is a method of adding zinc ions to a culture medium (Japanese Patent Laid-Open No. 2000-279164); a method for obtaining a glutathione-rich yeast strain using cadmium resistance and macrolide resistance as indicators (Japan) (Japanese Laid-Open Patent Publication No. 2006-42637, Japanese Laid-Open Patent Publication No. 2006-42638). As described in Japanese Patent Application Laid-Open No. 2011-103789, it can also be obtained by extraction of mutant yeast cells. Alternatively, a commercially available yeast extract may be used. For example, there are "Hithionextract" YH-15 and YH-D18 manufactured by KOHJIN Life Sciences.
麩胱甘肽濃度的測定方法係以DTNB-HPLC法(Journal of Chromatography,194(1980)424-428)進行。本案的麩胱甘肽含量係指合併還原型及氧化型麩胱甘肽的總麩胱甘肽含量。 The method for measuring the glutathione concentration was performed by a DTNB-HPLC method (Journal of Chromatography, 194 (1980) 424-428). The glutathione content in this case refers to the total glutathione content of a combination of reduced and oxidized glutathione.
本發明中,由於酵母萃取物中之成分與麩胱甘肽的加乘效果,藉由對於麩胱甘肽含量較低、或不含麩胱甘肽的酵母萃取物添加麩胱甘肽亦可製成含麩胱甘肽之酵母萃取物。 In the present invention, due to the synergistic effect of the ingredients in the yeast extract and glutathione, it is also possible to add glutathione to a yeast extract that has a low content of glutathione or does not contain glutathione Made of yeast extract containing glutathione.
本發明提供以含有上述之本發明富含麩胱甘肽之酵母萃取物為特徵的飲食品、化妝品、皮膚外用劑或醫藥品。 The present invention provides a food or drink, a cosmetic, a skin external preparation, or a medicinal product characterized by containing the above-mentioned glutathione-rich yeast extract of the present invention.
本發明中的飲食品係指摻合有上述組成物的食品、飲品、嗜好品、補給品等經口攝取者。其形態不特別限定,可以採用:可製成麵包類、麵類等主食者; 可製成乳酪、火腿、維也納香腸、魚貝類加工品等副食者;果汁飲料、碳酸飲料、乳飲料等飲料;餅乾、蛋糕、果凍、布丁、糖果、優格等嗜好品等。又,作為補給品之形態亦不特別限定,亦可採用錠劑、膠囊、軟膠囊、營養飲料狀的形態。 The food and drink in the present invention refers to a person who orally ingests foods, drinks, hobby products, and supplements with the above composition blended. The form is not particularly limited, and can be used: those who can make staple foods such as bread and noodles; It can be made into non-staple food such as cheese, ham, viennese sausage, processed fish and shellfish; fruit juice, carbonated beverage, milk beverage and other beverages; biscuits, cake, jelly, pudding, candy, yogurt, etc. Moreover, the form of a supplement is not specifically limited, The form of a tablet, a capsule, a soft capsule, and a nutrition drink can also be used.
飲食品中的上述組成物的摻合量只要具有黑色素產生抑制效果則不特別限定,例如含麩胱甘肽之酵母萃取物,相對於飲食品的質量100g含有10pg~20g即可。其中較佳為100pg~2g,更佳為10ng~500mg。 The blending amount of the above composition in food and drink is not particularly limited as long as it has a melanin production suppressing effect. For example, a yeast extract containing glutathione may contain 10 pg to 20 g with respect to 100 g of food and drink. Among them, it is preferably 100 pg to 2 g, and more preferably 10 ng to 500 mg.
本發明之化妝品係指摻合有上述組成物的化妝水、乳液、粉底、口紅等。 The cosmetic of the present invention refers to a lotion, an emulsion, a foundation, a lipstick, and the like mixed with the above composition.
組成物的摻合量不特別限定,例如相對於上述組成物的質量100g含有10pg~20g即可。其中較佳為100pg~2g,更佳為10ng~500mg。 The blending amount of the composition is not particularly limited, and for example, it may contain 10 pg to 20 g with respect to 100 g of the mass of the composition. Among them, it is preferably 100 pg to 2 g, and more preferably 10 ng to 500 mg.
又本發明可作為皮膚外用劑等的醫藥品使用。雖意指摻合有上述組成物的洗劑、乳劑、軟膏、噴霧劑、貼劑(材)等之形狀者,惟其形態不特別限定,只要可發揮本發明目的之效果即可,可為任意形態。 The present invention can also be used as a pharmaceutical for external use on skin. Although it means a shape of a lotion, an emulsion, an ointment, a spray, a patch (material) and the like in which the above composition is blended, the form is not particularly limited as long as the effect of the purpose of the present invention can be exhibited, it may be any form.
醫藥品中的組成物的摻合量不特別限定,例如富含麩胱甘肽之酵母萃取物,相對於組成物的質量100g10pg~20g即可。其中較佳為100pg~2g,更佳為10ng~500mg。 The blending amount of the composition in the pharmaceutical is not particularly limited. For example, a yeast extract rich in glutathione may be 10 pg to 20 g with respect to the mass of the composition. Among them, it is preferably 100 pg to 2 g, and more preferably 10 ng to 500 mg.
[實施例] [Example]
以下舉出實施例對本發明更詳細加以說明,惟本發明不受此等實施例所限定。 The following examples are used to describe the present invention in more detail, but the present invention is not limited by these examples.
(實施例1) (Example 1)
含麩胱甘肽之酵母萃取物的製造 Manufacture of glutathione-containing yeast extract
(酵母的培養) (Culture of yeast)
預先在含有YPD培養基(酵母萃取物1%、聚腖2%、葡萄糖2%)的三角燒瓶中將Candida utilis CS7529株(FERMP-3340)進行種母培養,在30L容量發酵槽中,於18L培養基中將其進行1~2%的接菌。培養基組成使用葡萄糖4%、磷酸一銨0.3%、硫酸銨0.161%、氯化鉀0.137%、硫酸鎂0.08%、硫酸銅1.6ppm、硫酸鐵14ppm、硫酸錳16ppm、硫酸鋅14ppm。培養條件採用pH4.0、培養溫度30℃、通氣量1vvm、攪拌600rpm進行,並添加氨來進行pH的控制。進行16小時的菌體培養後,回收培養液,藉由離心分離集菌,而得到180g的濕潤酵母菌體。 Candida utilis CS7529 strain (FERMP-3340) was seed-cultured in an Erlenmeyer flask containing YPD medium (1% yeast extract, 2% polyfluorene, and 2% glucose) in a 30L capacity fermentation tank in 18L It was inoculated with 1 ~ 2% in the medium. The composition of the culture medium was 4% glucose, 0.3% monoammonium phosphate, 0.161% ammonium sulfate, 0.137% potassium chloride, 0.08% magnesium sulfate, 1.6 ppm copper sulfate, 14 ppm iron sulfate, 16 ppm manganese sulfate, and 14 ppm zinc sulfate. The culture conditions were performed using pH 4.0, a culture temperature of 30 ° C, an aeration volume of 1 vvm, and stirring at 600 rpm, and addition of ammonia to control the pH. After 16 hours of bacterial cell culture, the culture solution was recovered and the bacteria were collected by centrifugation to obtain 180 g of moist yeast cells.
(酵母萃取物的萃取) (Extraction of yeast extract)
藉由將菌體培養後的濕潤酵母菌體懸浮於蒸餾水並重複離心分離來進行清洗。清洗後再度將濕潤菌體懸浮於蒸餾水、或將經冷凍乾燥或熱風乾燥的乾燥菌體懸浮於蒸餾水,並調整為以下條件來進行萃取物萃取。 The moist yeast cells after culturing the cells were suspended in distilled water and repeatedly centrifuged to perform washing. After washing, the wet bacteria were suspended in distilled water again, or the freeze-dried or hot air-dried bacteria were suspended in distilled water, and adjusted to the following conditions to extract the extract.
自消化:以1N HCl調整為pH5.0後,在55℃下攪拌4小時 Self-digestion: After adjusting to pH 5.0 with 1N HCl, stir at 55 ° C for 4 hours
酵素萃取:以1N NaOH調整為pH7後,以細胞壁溶解酵素(Tunicase)或蛋白酶在55℃下進行4小時攪拌萃取 Enzyme extraction: After adjusting to pH 7 with 1N NaOH, use cell wall-dissolving enzyme (Tunicase) or protease to perform extraction at 55 ° C for 4 hours with stirring.
酸萃取:以1N硫酸調整為pH2以下後,在65℃下進行2分鐘攪拌萃取 Acid extraction: After adjusting to pH 2 or less with 1N sulfuric acid, perform stirring extraction at 65 ° C for 2 minutes
鹼萃取:以2N NaOH調整為pH13後,在70℃下進行20分鐘攪拌萃取 Alkali extraction: After adjusting to pH 13 with 2N NaOH, carry out stirring extraction at 70 ° C for 20 minutes
(酵母萃取物的乾燥) (Drying of yeast extract)
萃取後以離心分離分離酵母殘渣,並將萃取物濃縮後,進行冷凍乾燥或熱風乾燥而得到含麩胱甘肽之酵母萃取物。還原型麩胱甘肽含量為15.51%、麩胱甘肽含量(總麩胱甘肽含量)為17.68%。 After extraction, the yeast residue is separated by centrifugation, and the extract is concentrated, and then freeze-dried or hot air dried to obtain a glutathione-containing yeast extract. The reduced glutathione content was 15.51%, and the glutathione content (total glutathione content) was 17.68%.
(黑色素產生抑制效果的確認) (Confirmation of melanin production suppressing effect)
依循以下程序測定黑色素產生抑制效果。 The melanin production inhibitory effect was measured by the following procedure.
<黑色素產生抑制效果的驗證> <Verification of melanin production inhibitory effect>
將B16小鼠黑色素瘤細胞播種於6井平板(2×104/井),進行24小時前培養(5%CO2、37℃)。培養液使用含5%胎牛血清的D-MEM培養基。其後,更換為新鮮培養基,其中添加麩胱甘肽(比較例1)、富含麩胱甘肽之酵母萃取物(實施例1)使最終濃度以還原型麩胱甘肽換算計成為1.0mM,及已知有黑色素產生抑制效果的乳酸鈉(比較例2)使最終濃度成為50mM。在播種後第4日去除培養基,將平板以PBS(磷酸緩衝生理食鹽水)清洗後,以0.25%胰蛋白酶EDTA剝離,並藉由離心(10000rpm、3min)操作回收團粒(細胞)。回收之團粒以PBS清洗2次後,以1mL的PBS調整細胞浮游液而將0.8mL使用於黑色素量的測定、將0.2mL使用於蛋白質的定量。 B16 mouse melanoma cells were seeded on a 6-well plate (2 × 10 4 / well) and cultured 24 hours before (5% CO 2 , 37 ° C.). D-MEM medium containing 5% fetal bovine serum was used as the culture medium. Thereafter, it was replaced with a fresh medium, and glutathione (Comparative Example 1) and a yeast extract rich in glutathione (Example 1) were added so that the final concentration became 1.0 mM in terms of reduced glutathione. And sodium lactate (Comparative Example 2) which is known to have a melanin production inhibitory effect, so that the final concentration becomes 50 mM. On the fourth day after sowing, the medium was removed, the plate was washed with PBS (phosphate-buffered saline), and then stripped with 0.25% trypsin EDTA, and pellets (cells) were recovered by centrifugation (10,000 rpm, 3 min). After the recovered pellets were washed twice with PBS, the cell suspension was adjusted with 1 mL of PBS, and 0.8 mL was used to measure the amount of melanin, and 0.2 mL was used to quantify the protein.
將作為黑色素量的測定用之回收團粒以150μL的1N NaOH熔解(100℃、10分),利用微盤分析儀(microplate reader)測定405nm的吸光度。作為蛋白質的回收定量用之團粒以BCA法進行蛋白質的定量。以添加水者為對照組,求取令對照組為100%時,添加比較例1、2而培養的細胞之每單位蛋白質的黑色素量作為黑色素生成率。 The recovered pellets used for measuring the amount of melanin were dissolved in 150 μL of 1N NaOH (100 ° C., 10 minutes), and the absorbance at 405 nm was measured using a microplate reader. The pellets used for protein recovery and quantification were quantified by the BCA method. The water-added person was used as a control group. When the control group was set to 100%, the amount of melanin per unit protein of the cells cultured in Comparative Examples 1 and 2 was added as the melanin production rate.
將實施例1之結果示於圖1。如圖1所示,就麩胱甘肽單獨時(比較例1),黑色素產生抑制率與對照組相比為約40%,相對於此,本案發明之富含麩胱甘肽之酵母萃取物的黑色素產生抑制率與對照組相比為約85%,可判斷與麩胱甘肽單獨時相比具有2倍以上的黑色素產生抑制效果。可認為此係因麩胱甘肽與酵母萃取物中的麩胱甘肽以外之成分顯示加乘效果所致。因此,本發明之富含麩胱甘肽之酵母萃取物可作為食品使用,並可發揮優良的黑色素產生抑制效果,而有用於作為黑色素產生抑制劑。 The results of Example 1 are shown in FIG. 1. As shown in FIG. 1, when glutathione is alone (Comparative Example 1), the melanin production inhibition rate is about 40% compared with the control group. In contrast, the glutathione-rich yeast extract of the present invention is The melanin production inhibitory rate was about 85% compared with the control group, and it was judged that the melanin production inhibitory effect was twice or more than that of glutathione alone. It is considered that this is because the components other than glutathione in the glutathione and the yeast extract exhibit a multiplier effect. Therefore, the glutathione-enriched yeast extract of the present invention can be used as a food, and can exhibit an excellent melanin production inhibitory effect, and is useful as a melanin production inhibitor.
Claims (1)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2014070964 | 2014-03-31 | ||
| JP2014-070964 | 2014-03-31 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TW201620396A TW201620396A (en) | 2016-06-16 |
| TWI670016B true TWI670016B (en) | 2019-09-01 |
Family
ID=54240197
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW104109904A TWI670016B (en) | 2014-03-31 | 2015-03-27 | Use of yeast extract |
Country Status (3)
| Country | Link |
|---|---|
| JP (1) | JPWO2015151867A1 (en) |
| TW (1) | TWI670016B (en) |
| WO (1) | WO2015151867A1 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102876448B1 (en) * | 2020-12-30 | 2025-10-24 | 주식회사 삼양사 | Yeast extract containing tripeptide and method thereof |
| JP7089305B1 (en) * | 2021-04-15 | 2022-06-22 | 株式会社ファーマフーズ | Skin whitening composition |
| EP4659758A1 (en) | 2023-01-31 | 2025-12-10 | Mitsubishi Corporation Life Sciences Limited | Anti-aging composition |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002020300A (en) * | 2000-07-07 | 2002-01-23 | Ichimaru Pharcos Co Ltd | Cosmetic composition |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3040992B2 (en) * | 1998-06-11 | 2000-05-15 | 株式会社ファンケル | Food composition |
| JP2001354570A (en) * | 2000-06-15 | 2001-12-25 | Ichimaru Pharcos Co Ltd | Immunoactivating agent and cosmetic using the same |
| JP2003252742A (en) * | 2002-02-28 | 2003-09-10 | Kose Corp | Melanocyte dendrite formation inhibitor and skin care preparation containing the same |
| JP2006347975A (en) * | 2005-06-17 | 2006-12-28 | Bio Solutions:Kk | Oral composition for cardiovascular disease prophylaxis and amelioration |
| JP2006347988A (en) * | 2005-06-20 | 2006-12-28 | Pola Chem Ind Inc | Cosmetics containing natural yeast extract |
| JP5561889B2 (en) * | 2006-09-19 | 2014-07-30 | 株式会社アリミノ | Active oxygen radical removing composition and hair-containing active oxygen radical removing agent containing the same |
| JP2008303180A (en) * | 2007-06-08 | 2008-12-18 | Noevir Co Ltd | Skin-lightening agent, skincare preparation for external use, and functional oral composition |
| JP2009107962A (en) * | 2007-10-29 | 2009-05-21 | Asahi Breweries Ltd | Yeast extract-containing composition |
| CN102008426A (en) * | 2009-09-08 | 2011-04-13 | 上海利盛生化有限公司 | Cosmetic composition with function of eliminating free radical |
| EP2554656B1 (en) * | 2010-03-26 | 2018-05-16 | Asahi Group Holdings, Ltd. | Method for culturing yeast |
-
2015
- 2015-03-20 WO PCT/JP2015/058510 patent/WO2015151867A1/en not_active Ceased
- 2015-03-20 JP JP2016511540A patent/JPWO2015151867A1/en active Pending
- 2015-03-27 TW TW104109904A patent/TWI670016B/en active
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002020300A (en) * | 2000-07-07 | 2002-01-23 | Ichimaru Pharcos Co Ltd | Cosmetic composition |
Also Published As
| Publication number | Publication date |
|---|---|
| TW201620396A (en) | 2016-06-16 |
| WO2015151867A1 (en) | 2015-10-08 |
| JPWO2015151867A1 (en) | 2017-04-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI652992B (en) | Yeast-derived seasoning, method for producing yeast protein composition, and yeast-derived seasoning | |
| Alsayadi et al. | Antioxidant potency of water kefir | |
| JP4163631B2 (en) | Fermentation composition of spicy varieties of chili pepper and its use | |
| JP5467433B2 (en) | Seaweed fermentation composition and method for producing the same | |
| CN110249055A (en) | Fermentation material and its manufacturing method | |
| WO2018225557A1 (en) | Extracellular polysaccharide of lactic acid bacteria and use thereof | |
| JP4854199B2 (en) | Functional material obtained by re-fermenting liquefied sake lees | |
| TWI670016B (en) | Use of yeast extract | |
| JP6281890B2 (en) | Use of Torula yeast-derived glucosylceramide as a whitening agent | |
| CN1917856B (en) | Oral skin moisturizer and functional food and beverage | |
| JP2018033424A (en) | Taste modifying composition | |
| JP6172700B2 (en) | Use of Torula yeast-derived glucosylceramide as a fibroblast growth promoter | |
| TWI679982B (en) | Use of lactic acid bacteria fermented material for producing inhibitor of pentosine | |
| TW202317166A (en) | Uses of golden passion fruit ferment for improving skin condition and anti-photoaging | |
| JP6301522B1 (en) | Antihypertensive composition and method for producing the same | |
| JP6261031B2 (en) | Use of Torula yeast-derived glucosylceramide as a colon cancer inhibitor | |
| JP6629512B2 (en) | Composition for promoting collagen production containing glucosylceramide derived from Torula yeast | |
| KR20220130967A (en) | Fermented extract of Young Antler with Enhanced Anti-oxidant Activity | |
| JP6397814B2 (en) | Method for producing copper-containing yeast extract, method for producing food, and method for restoring green color of vegetable | |
| KR20180065825A (en) | Fermentation Condiment of Sea Tangle Extract Method | |
| CN105821099A (en) | Process for preparing antioxidant peptides from pinctada martensii by adopting fermentation method | |
| JP2019136027A (en) | Fermentation product | |
| JP2019033706A (en) | Method for producing D-amino acid | |
| KR20180067897A (en) | Method for producing quinoa microbial fermentation rich in l-carnitine | |
| JP2025022429A (en) | Lactic acid bacteria fermentation composition and method for producing same |